Education
About Us
Working with TipRanks
Follow Us
Alvotech (ALVO)
:ALVO
ALVO Stock Chart & Stats
$8.59
$0.06(0.46%)
At close: 4:00 PM EST
$8.59
$0.06(0.46%)
Day’s Range― - ―
52-Week Range$7.35 - $13.70
Previous CloseN/A
Volume41.59K
Average Volume (3M)372.30K
Market Cap
$2.54B
Enterprise Value$3.87B
Total Cash (Recent Filing)$151.45M
Total Debt (Recent Filing)$1.27B
Price to Earnings (P/E)38.7
Beta0.71
Next Earnings
Nov 12, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding301,805,660
10 Day Avg. Volume351,577
30 Day Avg. Volume372,295
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.53
Enterprise Value/Revenue6.91
Enterprise Value/Gross Profit12.87
Enterprise Value/Ebitda18.67
Forecast
1Y Price Target
$18.67Price Target Upside117.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Business Model ValidationConsistent execution has validated the business model.
Global PartnershipsGlobal partnerships maximise the geographic reach of the portfolio, while the royalty/milestone-based business model should lead to elevated margins.
Pipeline DevelopmentsPositive developments in the pipeline with 3 new biosimilar launches by the end of 2025 and a visible pipeline in the mid and long-term.
Bears Say
Alvotech News
ALVO FAQ
What was Alvotech’s price range in the past 12 months?
Alvotech lowest stock price was $7.35 and its highest was $13.70 in the past 12 months.
What is Alvotech’s market cap?
Alvotech’s market cap is $2.54B.
When is Alvotech’s upcoming earnings report date?
Alvotech’s upcoming earnings report date is Nov 12, 2025 which is in 13 days.
How were Alvotech’s earnings last quarter?
Alvotech released its earnings results on Aug 13, 2025. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of -$0.046 by $0.076.
Is Alvotech overvalued?
According to Wall Street analysts Alvotech’s price is currently Undervalued.
Does Alvotech pay dividends?
Alvotech does not currently pay dividends.
What is Alvotech’s EPS estimate?
Alvotech’s EPS estimate is -0.02.
How many shares outstanding does Alvotech have?
Alvotech has 301,805,660 shares outstanding.
What happened to Alvotech’s price movement after its last earnings report?
Alvotech reported an EPS of $0.03 in its last earnings report, beating expectations of -$0.046. Following the earnings report the stock price went down -5.357%.
Which hedge fund is a major shareholder of Alvotech?
Currently, no hedge funds are holding shares in ALVO
Alvotech Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.67 (117.35% Upside)
$18.67 (117.35% Upside)
Blogger Sentiment
Bullish
ALVO Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 297.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 4.5%
Last 30 Days ▲ 11.4%
Last 30 Days ▲ 11.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.84%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
30.35%
Trailing 12-Months
Company Description
Alvotech
Alvotech (ALVO) is a biotechnology company focused on developing and manufacturing biosimilars, which are biologic medical products highly similar to already approved reference products. The company operates primarily in the pharmaceutical sector, specializing in monoclonal antibodies and other biologics. Alvotech aims to provide affordable access to high-quality medicines for patients worldwide by leveraging its proprietary technology platform and expertise in large-scale bioprocessing.
ALVO Company Deck
ALVO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong overall performance by Alvotech, with significant revenue growth, positive cash flow, and strategic market expansion. However, the lumpiness in licensing revenues and anticipated challenges in the U.S. market pose some concerns.View all ALVO earnings summariesALVO Stock 12 Month Forecast
Average Price Target
$18.67
▲(117.35% Upside)
Technical Analysis
Perrigo Company
―
Supernus Pharmaceuticals
―
ANI Pharmaceuticals
―
HUTCHMED
―
Amneal Pharmaceuticals
―
Ownership Overview
―
Insiders
1.59% Mutual Funds
2.95% Other Institutional Investors
95.07% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---